Helius Medical Technologies Inc. (HSDT) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
642 NEWTOWN YARDLEY ROAD NEWTOWN, PA 18940 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 5,182 | 14,549 | 11,005 | 3,331 | 5,459 | 25,583 | |||
| Cash and cash equivalents | 5,182 | 14,549 | 11,005 | 3,331 | 5,459 | 25,583 | |||
| Receivables | 637 | 343 | 251 | 230 | 574 | 275 | |||
| Inventory, net of allowances, customer advances and progress billings | 457 | 589 | 476 | 389 | 598 | 392 | |||
| Inventory | 457 | 589 | 476 | 389 | 598 | 392 | |||
| Prepaid expense | 689 | 817 | 862 | 735 | 610 | 447 | |||
| Deferred costs | 140 | ||||||||
| Other current assets | 264 | ||||||||
| Other undisclosed current assets | 333 | 399 | |||||||
| Total current assets: | 7,438 | 16,697 | 12,594 | 4,685 | 7,241 | 26,961 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 52 | 103 | 3 | 90 | 552 | ✕ | |||
| Property, plant and equipment | 178 | 347 | 409 | 486 | 712 | 554 | |||
| Long-term investments and receivables | 294 | ||||||||
| Accounts and financing receivable, after allowance for credit loss | 294 | ||||||||
| Intangible assets, net (including goodwill) | 24 | 140 | 1,096 | 1,286 | 1,824 | ||||
| Goodwill | 763 | 759 | 1,242 | ||||||
| Intangible assets, net (excluding goodwill) | 24 | 140 | 333 | 527 | 582 | ||||
| Other noncurrent assets | 18 | 18 | |||||||
| Total noncurrent assets: | 254 | 590 | 1,508 | 1,862 | 3,106 | 866 | |||
| TOTAL ASSETS: | 7,692 | 17,287 | 14,102 | 6,547 | 10,347 | 27,827 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,623 | 1,907 | 2,502 | 2,084 | 3,195 | 4,204 | |||
| Accounts payable | 531 | 627 | 1,069 | 747 | 1,676 | 2,392 | |||
| Accrued liabilities | 1,092 | 1,280 | 1,433 | 1,337 | 1,519 | 1,812 | |||
| Deferred revenue | 27 | 148 | 281 | 430 | ✕ | ||||
| Debt | 172 | ||||||||
| Derivative instruments and hedges, liabilities | 5 | 13,769 | |||||||
| Other undisclosed current liabilities | 256 | 54 | 3 | 59 | |||||
| Total current liabilities: | 1,879 | 1,988 | 2,653 | 2,424 | 3,802 | 17,973 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation: | 32 | 465 | |||||||
| Liabilities, other than long-term debt | 3,335 | 7,148 | 193 | 220 | 245 | ||||
| Deferred revenue | 175 | 193 | 220 | 245 | ✕ | ||||
| Operating lease, liability | 12 | 56 | 32 | 465 | ✕ | ||||
| Derivative instruments and hedges, liabilities | 3,323 | 6,917 | |||||||
| Other undisclosed noncurrent liabilities | 128 | ||||||||
| Total noncurrent liabilities: | 3,463 | 7,148 | 193 | 252 | 710 | ||||
| Total liabilities: | 5,342 | 9,136 | 2,846 | 2,676 | 4,512 | 17,973 | |||
| Equity | |||||||||
| Equity, attributable to parent | 2,350 | 8,151 | 11,256 | 3,871 | 5,835 | 9,854 | |||
| Common stock | 1 | 28 | 4 | 1 | 31 | 26 | |||
| Additional paid in capital | 162,979 | 159,618 | 149,412 | 123,872 | 111,479 | 105,411 | |||
| Accumulated other comprehensive loss | (673) | (388) | (1,125) | (1,099) | (902) | (591) | |||
| Accumulated deficit | (159,957) | (151,107) | (137,035) | (118,903) | (104,773) | (94,992) | |||
| Total equity: | 2,350 | 8,151 | 11,256 | 3,871 | 5,835 | 9,854 | |||
| TOTAL LIABILITIES AND EQUITY: | 7,692 | 17,287 | 14,102 | 6,547 | 10,347 | 27,827 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 644 | 787 | 522 | 661 | 500 | 478 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (583) | (463) | (298) | (388) | (846) | |||
| Other undisclosed gross profit | 996 | |||||||
| Gross profit: | 61 | 324 | 224 | 273 | 650 | 478 | ||
| Operating expenses | (12,489) | (15,840) | (18,366) | (14,659) | (24,646) | (27,153) | ||
| Operating loss: | (12,428) | (15,516) | (18,142) | (14,386) | (23,996) | (26,675) | ||
| Nonoperating income (expense) | 3,578 | 1,444 | 10 | 256 | 14,215 | (1,948) | ||
| Gain (loss), foreign currency transaction, before tax | 25 | 872 | ||||||
| Other nonoperating income | 80 | 7 | 63 | 95 | ||||
| Loss from continuing operations before equity method investments, income taxes: | (8,850) | (14,072) | (18,132) | (14,130) | (9,781) | (28,623) | ||
| Other undisclosed income from continuing operations before income taxes | 28,260 | 19,562 | 57,246 | |||||
| Income (loss) from continuing operations: | (8,850) | (14,072) | (18,132) | 14,130 | 9,781 | 28,623 | ||
| Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (18,132) | 14,130 | 9,781 | 28,623 | |
| Other undisclosed net loss | (28,260) | |||||||
| Net income (loss): | (8,850) | (14,072) | (18,132) | (14,130) | 9,781 | 28,623 | ||
| Other undisclosed net loss attributable to parent | (19,562) | (57,246) | ||||||
| Net loss available to common stockholders, diluted: | (8,850) | (14,072) | (18,132) | (14,130) | (9,781) | (28,623) | ||
Comprehensive Income ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (8,850) | (14,072) | (18,132) | (14,130) | 9,781 | 28,623 | ||
| Other comprehensive income | 737 | |||||||
| Comprehensive income (loss): | (8,850) | (13,335) | (18,132) | (14,130) | 9,781 | 28,623 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (285) | (26) | (197) | (19,873) | (57,884) | |||
| Comprehensive loss, net of tax, attributable to parent: | (9,135) | (13,335) | (18,158) | (14,327) | (10,092) | (29,261) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.